U of Alberta Researchers Win $120K Grant to Develop Metabolite-Based Lung Cancer Test
Mar 16, 2021 | staff reporter NEW YORK — BioMark Diagnostics said on Tuesday that its collaborators at the University of Alberta’s Metabolomics Innovation Centre have been awarded a C$150,000 (US$120,327) grant to evaluate the company’s metabolite biomarker panel for early lung cancer detection. The funding is being provided through a cancer technology grant program sponsored by […]
BIOMARK’S COLLABORATOR RECEIVES FUNDING TO VALIDATE ITS BIOMARKER PANEL FOR THE EARLY DETECTION OF LUNG CANCER
Vancouver, British Columbia – (March 16, 2021) – BioMark Diagnostics Inc. (“BioMark”) (CSE: BUX) (FSE: 20B) (OTCMKTS: BMKDF) is pleased to announce today that its sponsored research collaboration with The Metabolomics Innovation Centre (TMIC) was successful in receiving funding from the Novel Technology Application in Cancer Prevention and Early Detection Spark Grants competition. This comes […]
